Danny Yeung, the Prenetics CEO. Photo: KY Cheng
Danny Yeung, the Prenetics CEO. Photo: KY Cheng

Adrian Cheng-backed start-up Prenetics acquires majority stake in Hong Kong biotech firm ACT Genomics

  • Prenetics has acquired the stake for 19.9 million of its ordinary shares and US$20 million in cash
  • Company wants to democratise testing and make cancer genomics accessible to all, CEO Danny Yeung says

Danny Yeung, the Prenetics CEO. Photo: KY Cheng
Danny Yeung, the Prenetics CEO. Photo: KY Cheng
READ FULL ARTICLE